Metal Hypersensitivity Reactions Following Spinal Implants Authors: Joseph Abbo, Jacob Thomas, Christian Stipho, Erik Nakken, Rakesh Patel, Joshua D. Piche, IIyas Aleem Published: 2026 ABSTRACT Background:Metal hypersensitivity reactions are infrequently reported but clinically significant after spinal implant surgery. Clinical presentation can mimic infection or mechanical failure, making diagnosis difficult. Evidence to guide diagnosis and management is largely limited to short case series and case reports. The purpose of this study was to systematically review the clinical presentation, diagnostic methods, and outcomes of metal hypersensitivity associated with spinal implants.Methods:A systematic review was conducted of PubMed, Embase, and Scopus from inception through June 22, 2026, in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Title and abstract screening, full-text review, and data extraction were performed independently by 2 reviewers with conflicts resolved by a third reviewer. Eligible studies included adult patients with suspected or confirmed metal hypersensitivity following spinal implant surgery that reported patient-level clinical outcomes.Results:Fifteen studies with a total of 19 patients met inclusion criteria (53% female, 42% male, and 5% not reported). The median patient age was 47 years (range, 19-69). Twelve procedures (63%) were fusion-based, while 7 (37%) were motion preserving, including disk arthroplasty and artificial facet replacement systems. Common clinical presentations included persistent pain, with 8 patients (42%) exhibiting dermatologic manifestations. Metal hypersensitivity was immunologically confirmed by positive patch testing and/or lymphocyte transformation testing in 11 patients (58%), while 8 (42%) were diagnosed clinically. Onset of symptoms ranged from immediately postoperatively to 15 years after implantation. Eighteen patients underwent removal or revision with clinical improvement in 14 of 16 with a reported outcome (88%).Conclusion:Metal hypersensitivity reactions following spinal implants are infrequently reported but may present either immediately or in a delayed manner with symptoms that mimic more common postoperative complications, such as infection or pseudarthrosis, or may present with dermatologic manifestations. In cases where other etiologies are ruled out, hardware removal was frequently, though not invariably, associated with clinical improvement, which was reported narratively rather than by validated outcome measures.Level of Evidence:Therapeutic Level V. See Instructions for Authors for a complete description of levels of evidence. Metal hypersensitivity reactions are a recognized but incompletely understood complication associated with orthopaedic implants1-3. Although metallic biomaterials such as cobalt, chromium, and titanium are generally considered biocompatible, immune-mediated reactions have been increasingly reported across orthopaedic subspecialties1,3,4. Given the widespread use of metallic implants, even relatively rare hypersensitivity reactions may contribute to clinically meaningful patient morbidity2,3. While these complications are well described in joint arthroplasty2,4,5, their prevalence and impact in spine surgery remain uncertain2,6, and immune-mediated reactions may be overlooked among more common mechanical complications6,7. Two distinct entities must be distinguished. Metal hypersensitivity is a delayed-type (type IV), T-cell–mediated immune response to metal ions, whereas adverse local tissue reaction, including aseptic lymphocyte-dominated vasculitis-associated lesion, is an inflammatory response to wear debris and metal degradation products that can occur in the absence of true allergy. These processes may coexist, particularly in metal-on-metal constructs, and distinguishing them is a central diagnostic challenge addressed in this review3. Metal ions released through corrosion, wear, or micromotion can form hapten complexes that activate T-cell–mediated immunity; particulate debris may also promote inflammatory signaling, osteolysis, and local tissue damage1,3,7. Clinically, hypersensitivity reactions often present with nonspecific findings such as pain, swelling, and dermatologic changes, which can mimic infection or mechanical failure2,5. Diagnosis remains challenging, as commonly used tests such as patch testing and lymphocyte transformation assays demonstrate inconsistent reliability3,4. As a result, metal hypersensitivity is frequently considered a diagnosis of exclusion after more common postoperative complications have been ruled out1,2. Despite increasing recognition of implant-related hypersensitivity in spine surgery, the current evidence base remains limited and largely consists of case reports and small case series, with a lack of standardized diagnostic criteria or management guidelines3. This highlights the need for a systematic synthesis of metal hypersensitivity reactions involving spinal implants. We therefore posed the following research question: Among patients undergoing spinal implant surgery, what are the clinical presentation, diagnostic methods, and outcomes after implant removal or revision in those with suspected or confirmed metal hypersensitivity, across the reported time course? The objective of this systematic review was to assemble and critically appraise the available patient-level evidence addressing this question. Methods Search Strategy PubMed, Embase, and Scopus were searched from inception through June 22, 2026, in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, using terms for spinal implants, metal hypersensitivity, and allergic reactions (Fig. 1; Table 1). A medical librarian was consulted in revising the search strategy. PRISMA flow diagram outlining the study selection process for the systematic review. PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Table 1Literature Search Strategy for PubMed, Embase, and ScopusDatabaseSearch StrategyPubMedString searched: (“Hypersensitivity”[Mesh] OR “metal hypersensitivity” OR “metal allergy” OR “metal sensitivity” OR “implant allergy” OR “implant hypersensitivity” OR “titanium allergy” OR “nickel allergy” OR cobalt OR chromium OR nickel OR titanium OR metallosis OR ALVAL OR “adverse local tissue reaction”) AND (“Spine”[Mesh] OR spine OR spinal OR “spinal fusion” OR arthrodesis OR “spinal instrumentation” OR “disc replacement” OR “disc arthroplasty” OR “total disc replacement”) AND (“Orthopedic Implants”[Mesh] OR implant OR implants OR hardware OR screw OR screws OR rod OR rods OR cage OR “pedicle screw” OR “interbody” OR prosthesis OR arthroplasty)EmbaseString searched: (“metal hypersensitivity” OR “metal allergy” OR “metal sensitivity” OR “implant allergy” OR “implant hypersensitivity” OR “titanium allergy” OR “titanium hypersensitivity” OR “cobalt allergy” OR “chromium allergy” OR “nickel allergy” OR metallosis OR ALVAL OR “adverse local tissue reaction”) AND (spine OR spinal OR “spinal fusion” OR arthrodesis OR “spinal instrumentation”) AND (implant OR implants OR hardware OR screw OR screws OR rod OR rods OR “pedicle screw” OR cage OR interbody OR arthroplasty OR “disc prosthesis” OR “disc replacement” OR “disc arthroplasty”)ScopusString searched: TITLE-ABS-KEY (“metal hypersensitivity” OR “metal allergy” OR “metal sensitivity” OR “implant allergy” OR “implant hypersensitivity” OR “titanium allergy” OR “titanium hypersensitivity” OR “cobalt allergy” OR “chromium allergy” OR “nickel allergy” OR metallosis OR ALVAL OR “adverse local tissue reaction”) AND TITLE-ABS-KEY (spine OR spinal OR “spinal fusion” OR arthrodesis OR “spinal instrumentation”) AND TITLE-ABS-KEY (implant OR implants OR hardware OR screw OR screws OR rod OR rods OR “pedicle screw” OR cage OR interbody OR arthroplasty OR “disc prosthesis” OR “disc replacement” OR “disc arthroplasty”)The Embase and Scopus strategies were expanded to mirror PubMed and to include sensitizing metal, wear/tissue reaction, and device terms; the strategy was developed with a medical librarian. Literature Search Strategy for PubMed, Embase, and Scopus The Embase and Scopus strategies were expanded to mirror PubMed and to include sensitizing metal, wear/tissue reaction, and device terms; the strategy was developed with a medical librarian. Eligibility Criteria Given the scarcity of higher-level evidence, we used intentionally inclusive eligibility criteria, accepting all study designs that reported patient-level data on suspected or confirmed metal hypersensitivity following spinal implant surgery. Eligible studies included adults with metallic spinal implants and patient-level data on suspected or confirmed hypersensitivity, including clinical presentation, diagnostic testing, management, and outcomes. Only symptoms that were new, persistent, or qualitatively worsened relative to the documented preoperative baseline were attributed to suspected hypersensitivity; the preoperative indication for surgery was not counted as a hypersensitivity symptom unless its character, timing, or associated dermatologic or systemic features changed postoperatively. Eligible designs included case reports, case series, and observational or comparative studies. We excluded nonspinal or nonmetallic implants; animal or in vitro studies; reviews, editorials, abstracts without full text, non-English or duplicate reports; and studies lacking patient-level outcomes or sufficient clinical detail. Study Selection After deduplication, 2 reviewers independently screened titles and abstracts in Covidence and performed full-text review; disagreements were resolved by discussion or a third reviewer. Included studies were assessed for clarity of presentation, diagnostic evaluation, exclusion of infection or mechanical failure, and postintervention outcomes. Data Extraction Two reviewers independently extracted study and patient characteristics, surgical details (procedure, implant type, composition, and location), diagnostic testing, clinical presentation, symptom onset, management, and outcomes using a standardized Covidence template; discrepancies were resolved by discussion or a third reviewer. Quality Assessment Joanna Briggs Institute (JBI) critical appraisal checklists for case reports and case series were applied independently by 2 reviewers, with disagreements resolved by discussion. The JBI appraisal reflects the completeness and quality of reporting rather than the strength of evidence; all included studies remain Level IV to V irrespective of their JBI score, and a high JBI score should not be interpreted as indicating robust evidence. Given the predominance of case-level evidence, Grading of Recommendations Assessment, Development, and Evaluation was not performed. Results Study Selection and Characteristics The search identified 452 records; after removal of 194 duplicates, 258 underwent title and abstract screening and 20 full-text review. Fifteen studies were included: 13 single-patient case reports8-20 and 2 case series with 2 and 4 patients, respectively21,22 (Fig. 1; Appendix Table A1). Patient Characteristics This review included data from 19 patients across 15 studies. The median age was 47 years (range, 19-69). The study consisted of 8 men (42.1%), 10 women (52.6%), with the sex of 1 patient (5.3%) not reported (Table 2). A documented history of metal allergy was present in 3 patients (15.8%), absent in 5 (26.3%), and not reported in 11 (57.9%); prior-allergy information was therefore unavailable for most patients. Table 2Clinical Characteristics, Diagnostic Methods, Implant Features, and OutcomesCharacteristicn (%)Patient characteristics Male8 (42) Female10 (53) Not reported1 (5) Median age47 Range19-69Type of implant Static12 (63) Dynamic7 (37)History of metal allergies Yes3 (16) No5 (26) Not reported11 (58)Implicated/sensitizing metal Cobalt-chromium6 (32) Titanium6 (32) Nickel3 (16) Cobalt2 (11) Not reported2 (11)Metal allergy diagnosis Allergy confirmed by testing11 (58) Diagnosed clinically8 (42)Patch test performed Performed (positive)12 performed; 11 positive, 1 negative (63 performed) Not performed7 (37)LTT performed Yes (positive)2 (11) performed; 2 positive Not performed17 (89)Revision or removal of hardware Yes18 (95) No1 (5) Improved if revised or removed14 of 16 with reported outcome (88) Time to symptom onsetImmediate to 15 yearsDiagnostic certainty Tier 1: Confirmed (positive patch and/or LTT)11 (58) Tier 2: Presumed/clinical (non-MoM, no positive test)4 (21) Tier 3: Wear-debris–confounded (MoM, untested)4 (21)LTT = lymphocyte transformation testing, and MoM = metal-on-metal. Clinical Characteristics, Diagnostic Methods, Implant Features, and Outcomes LTT = lymphocyte transformation testing, and MoM = metal-on-metal. Symptom Onset and Presentation Pain was the most common symptom (11 patients, 58%), followed by dermatologic findings—rash, erythema, pruritus, or dermatitis—in 8 (42%), neurologic symptoms in 5 (26%), edema in 3 (16%), systemic symptoms (fever, fatigue, weight loss, or drug rash with eosinophilia and systemic symptoms) in 3 (16%), and dysphagia in 2 (11%). Pain was predominantly axial and persistent in the confirmed and presumed-allergy cases and was frequently accompanied by dermatologic findings at or near the operative site, occurring despite a negative infection workup and imaging without hardware loosening or pseudarthrosis; in the metal-on-metal cases, pain was radicular and progressive and was associated with a demonstrable soft-tissue mass. Dermatologic findings were located near the operative site in several patients and were distant or generalized in others (e.g., the posterior trunk and axilla) (Table 3). Symptoms appeared within 6 months of surgery in 9 patients and after 6 months in 10 patients. Table 3Symptom Presentation and Time to Onset Following Spinal Implant SurgeryPatient No.StudyPainRashErythemaEdemaPruritusFeverFatigueWeight LossDRESSNeurologicDysphagiaAllergic Contact DermatitisDiffuse Exfoliative DermatitisTime to OnsetLevel of Evidence1Aoyama et al., 202210YYNNNNNNNNNNN8 yearsLevel V1Curley et al., 202014YNNNNNYNNNNNNPostoperative; exact time not reportedLevel V1El Habony et al., 20129YNNYNNNNNNNNNImmediately post-surgeryLevel V1Estupiñan et al., 202218YNYYYNNNNNNNN4 weeksLevel V1Goodwin et al., 201821YNNNNNNNNNNNN8 monthsLevel IV2Goodwin et al., 201821YNNNNNNNNYNNN1.5 yearsLevel IV1Guyer et al., 201122YNNNNNNNNYNNN10 monthsLevel IV2Guyer et al., 201122YNNNNNNNNYNNN1 yearLevel IV3Guyer et al., 201122NNNNNNNNNYNNN14 monthsLevel IV4Guyer et al., 201122NNNNNNNNNYNNN18 monthsLevel IV1Kim, 20208NNNNYNNNNNNYN15 yearsLevel V1Lagier et al., 201511YYYNYNNNNNYNN4 yearsLevel V1Nawaz and Wall, 200712NNNYNYNNYNNNY2 monthsLevel V1Saini et al., 202113NYNNNNNNNNNNNInitially 3 weeks; persisted and presented again at 2 yearsLevel V1Shang et al., 201415YNNNNNNNNNNNN3 monthsLevel V1Shi et al., 202317NYNNYNNNNNYNN1 monthLevel V1Towers and Kurtom, 202016NNNNNNYYNNNNN1 monthLevel V1Baral, 202619NNNNNNNNNNNNN9 months (implant extrusion/discharge)Level V1Wang et al., 202220YNNNNNNNNNNNN6 weeksLevel VTotal Y (n, %)11 (58%)4 (21%)2 (11%)3 (16%)4 (21%)1 (5%)2 (11%)1 (5%)1 (5%)5 (26%)2 (11%)1 (5%)1 (5%)DRESS = Drug rash with eosinophilia and systemic symptoms. Symptom Presentation and Time to Onset Following Spinal Implant Surgery DRESS = Drug rash with eosinophilia and systemic symptoms. Diagnostic Evaluation Patch testing was performed in 12 patients and was positive in 11; lymphocyte transformation testing (LTT) was performed in 2 patients and was positive in both. Overall, 11 patients (58%) had immunologic confirmation of hypersensitivity, whereas 8 (42%) were diagnosed clinically after exclusion of infection and mechanical failure, including 1 patient with a negative patch test. Diagnostic Certainty To address the difficulty of distinguishing type-IV hypersensitivity from adverse local tissue reaction to wear debris, each patient was classified into 1 of 3 certainty tiers (Appendix Table A1). Eleven patients (58%) had confirmed hypersensitivity (tier 1: positive patch test and/or LTT with exclusion of infection and mechanical failure); 4 (21%) had presumed hypersensitivity diagnosed clinically in non–metal-on-metal constructs (tier 2); and 4 (21%)—all 4 metal-on-metal total-disk–-replacement patients reported by Guyer et al.—were classified as indeterminate/wear-debris–confounded (tier 3). Among the 4 metal-on-metal total-disk–replacement patients22, intraoperative findings included metallosis and lymphocytic inflammatory tissue reaction, with epidural or retroperitoneal soft-tissue masses producing neural compression, recurrent stenosis, and in 1 case acute renal dysfunction from mass effect. None underwent confirmatory patch or lymphocyte transformation testing. These features are characteristic of adverse local tissue reaction to wear debris rather than primary metal hypersensitivity, and these cases are classified separately (tier 3) in the present analysis. Implant Characteristics Diagnostic evaluation identified hypersensitivity to several metals present in the spinal implants. The implicated metals were cobalt-chromium (n = 6), titanium (n = 6), nickel (n = 3), and cobalt (n = 2); the suspected metal was not reported in 2 patients. The metals listed denote the suspected sensitizing element identified by testing or clinical suspicion rather than the sole implant constituent; most implants were alloys (e.g., titanium alloy, which may contain trace nickel; cobalt-chromium-molybdenum), with full compositions provided in Appendix Table A1. Implants were classified as static or dynamic. Static constructs referred to fusion-based implants designed to eliminate motion, whereas dynamic constructs were motion-preserving devices intended to maintain segmental mobility. Static implants were placed in 12 of 19 patients (63.2%) and motion-preserving devices in 7 (36.8%). Most motion-preserving devices were metal-on-metal: the Kineflex-L and Kineflex-C and the Maverick total disk replacements (cobalt-chromium-molybdenum bearings) and the ACADIA facet replacement system (cobalt-containing metal-on-metal bearing). The remaining motion-preserving device, the Mobi-C cervical disk prosthesis, used a metal-on-polyethylene bearing (cobalt-chromium-molybdenum endplates with an ultra–high-molecular-weight polyethylene core); notably, that patient nonetheless had a positive chromium patch test, implicating the endplate alloy rather than the polymer core. No included device used a ceramic bearing surface. Management and Outcomes Eighteen of 19 patients (94.7%) underwent revision or removal of the implant. Infection was explicitly considered and excluded in the majority of patients, with negative cultures and/or normal inflammatory markers reported where testing was described. Of the 18 patients who underwent intervention, 12 required revision or reconstruction (most commonly conversion to a polyetheretherketone (PEEK) cage with steel or commercially pure titanium or conversion of a disk replacement to fusion) rather than simple explantation. Clinical improvement—defined throughout as author-reported resolution or meaningful reduction of symptoms, as no included study used a validated patient-reported outcome measure such as the visual analog scale (VAS), oswestry disability index (ODI), or neck disability index (NDI)—was reported in 14 of 16 patients (88%). Notably, both patients without clear improvement were tier-3 metal-on-metal cases, whereas every tier-1 and tier-2 patient who underwent removal improved. Follow-up duration was heterogeneous and frequently unreported (range, 6 weeks to 25 months; not reported in 9 patients). The 88% improvement rate therefore rests on uncontrolled, unblinded, single-patient observations without a comparator group and should be regarded as hypothesis-generating rather than as evidence of treatment efficacy. Quality Assessment Methodological quality was assessed using the JBI critical appraisal checklist for case reports and case series. Overall, study quality ranged from moderate to high, with scores of 6 to 8 out of 8 (Table 4). Most studies met the majority of appraisal criteria, with the most common limitation being incomplete reporting of adverse events. Variability in diagnostic evaluation and confirmation of hypersensitivity was also noted across studies. Table 4Methodological Quality Assessment Using the Joanna Briggs Institute ChecklistStudyQ1Q2Q3Q4Q5Q6Q7Q8Total YesLevel of EvidenceAoyama et al., 202210YYYYYYUY7Level VBaral, 202619YYYYYUUY6Level VCurley et al., 202014YYYYYYUY7Level VEl Habony et al., 20129YUYYYYUY6Level VEstupiñan et al., 202218YYYYYYYY8Level VGoodwin et al., 201821YYYYYYYY8Level IVGuyer et al., 201122YYYYYYYY8Level IVKim, 20208YYYYYYUY7Level VLagier et al., 201511YYYYYYUY7Level VNawaz and Wall, 200712YYYYYYYY8Level VSaini et al., 202113YYYYYYUY7Level VShang et al., 201415YYYYYYYY8Level VShi et al., 202317YYYYYYUY7Level VTowers and Kurtom, 202016YYYYYYYY8Level VWang et al., 202220YYYYYYYY8Level V Methodological Quality Assessment Using the Joanna Briggs Institute Checklist Discussion Metal hypersensitivity after spinal implants is infrequently reported and diagnostically uncertain but should be considered in selected patients with persistent or unexplained postoperative symptoms. Across the included studies (Appendix Table A1), patients most frequently presented with persistent axial or radicular pain, often accompanied by dermatologic manifestations such as rash, erythema, or pruritus. The clinical manifestations extended beyond these findings, with several patients demonstrating systemic symptoms including fatigue, weight loss, or neurologic deficits16,22, further complicating recognition. As demonstrated in the patient-level data (Appendix Table A1), these symptoms frequently overlapped within individuals, making it difficult to attribute findings to a single cause. The timing of symptom onset was highly variable, ranging from the immediate postoperative period to more than a decade after surgery. While approximately half of patients developed symptoms within 6 months, the other half presented in a delayed fashion, including cases occurring years after surgery8,10. This variability suggests that hypersensitivity reactions may not be solely related to early postoperative factors but may reflect cumulative metal exposure, corrosion, or changes in implant biomechanics over time1. Consistent with prior literature, metal hypersensitivity in this cohort was largely a diagnosis of exclusion. Many studies emphasized the need to first rule out infection, mechanical failure, or implant malposition before considering hypersensitivity11,12,14. This is particularly relevant in spine surgery, where common complications such as pseudarthrosis, adjacent segment disease, or recurrent stenosis may present with similar features. Several cases underwent extensive workup, including imaging, laboratory evaluation, and even reoperation, before hypersensitivity was suspected15,17. As a result, delayed diagnosis appears to be a consistent feature of this condition. Patch testing was most common but has limited specificity and inconsistent correlation with symptoms or implant failure; LTT was rarely used and lacks standardized interpretation thresholds1. Notably, 1 patient with a negative patch test was nonetheless diagnosed clinically, and the 4 metal-on-metal cases were diagnosed without any confirmatory immunologic testing, underscoring the absence of a reliable diagnostic gold standard. This limited specificity mirrors the arthroplasty literature, in which no current metal-sensitivity test is sufficiently reliable to independently guide treatment4. Corrosion, micromotion, and wear can release ions and particles that provoke local inflammation and type-IV hypersensitivity1,7. It remains unclear whether hypersensitivity is a primary driver of implant failure or a secondary response to wear debris from a failing construct, and our reclassification illustrates this directly: The metal-on-metal cases demonstrated metallosis, lymphocytic reaction, and mass effect characteristic of adverse local tissue reaction rather than primary allergy and were therefore classified separately (tier 3). The reactions most consistent with wear-particle generation rather than primary allergy occurred in the metal-on-metal total-disk–replacement cases (the Kineflex-L/Kineflex-C and Maverick devices; the 4 Guyer patients), none of which had confirmatory immunologic testing. By contrast, the metal-on-metal ACADIA facet-replacement cases (Goodwin) had positive cobalt patch testing, illustrating that confirmed hypersensitivity and wear-debris reaction can coexist in metal-on-metal constructs. This association is device-specific: Some metal-on-metal cervical prostheses (e.g., the Prestige) have not been associated with comparable wear-debris reactions, and no such device was included here. Titanium hypersensitivity was suspected or confirmed in several cases10,12,16-18,20, and trace nickel in many alloys complicates attribution to a single sensitizer. Symptom improvement following removal or revision is supportive of, but does not by itself establish, a causal relationship with metal hypersensitivity because revision may simultaneously address stenosis, instability, implant failure, or a wear-debris mass lesion; this caution applies with particular force to the metal-on-metal cases. Consistent with this, both treatment failures in this review occurred among the wear-debris–confounded metal-on-metal cases. Hardware removal is not without risk: It may precipitate instability, deformity progression, pseudarthrosis, neurologic injury, blood loss, and infection and frequently necessitates reinstrumentation. In this review, most patients required revision or reconstruction rather than simple explantation. The decision to remove hardware should therefore be individualized to construct stability and symptom severity and, where possible, deferred until fusion is established. From a clinical perspective, metal hypersensitivity should be considered in patients with persistent pain, dermatologic reactions, or unexplained systemic symptoms following spinal implant surgery, particularly after more common etiologies have been excluded. A detailed history of prior metal sensitivity may be helpful, although its predictive value remains limited. Routine preoperative screening is not supported by current evidence but may be considered in select patients with a strong history of metal allergy. A practical diagnostic and management algorithm is proposed (Fig. 2): recognition of the clinical pattern, assessment of metal-sensitivity history and timing of onset, exclusion of infection and mechanical causes, evaluation for adverse local tissue reaction in metal-on-metal constructs, allergy testing where hypersensitivity is suspected after common causes are excluded, multidisciplinary review, and hardware removal as a late-stage, individualized decision. Proposed diagnostic and management algorithm for suspected metal hypersensitivity following spinal implant surgery. Limitations include case-report/series design, selection bias, heterogeneous reporting, and inconsistent diagnostic criteria. Larger spine-complication cohorts report metal hypersensitivity among other adverse events and provide denominators that case-level reports lack; however, they generally do not provide the individual diagnostic criteria, confirmatory testing, implant composition, time course, and management outcomes required for the present synthesis, and in the absence of standardized diagnostic criteria, such aggregate counts cannot be reliably attributed to true hypersensitivity23. This review is therefore framed as a synthesis of patient-level evidence, with the consequent undercapture of cases embedded in large cohorts acknowledged as a limitation. The observed rate of improvement after removal must also be interpreted in light of publication and reporting bias because cases that improve after revision are more likely to be reported, likely overestimating the true effect of removal. This bias compounds the absence of standardized diagnostic criteria across the included reports. Finally, improvement was assessed narratively rather than with validated outcome measures, and follow-up was heterogeneous and often unreported. Although it appears to be infrequently reported, its true incidence cannot be determined from the available case-level evidence and may be underestimated owing to under-recognition. Future work should move beyond case-level reporting toward prospective registries of spinal-implant patients that capture preoperative allergy screening, standardized confirmatory testing (e.g., lymphocyte transformation testing with defined interpretation thresholds), explicit exclusion of infection and mechanical failure, validated patient-reported outcome measures before and after any revision, and clear separation of type-IV hypersensitivity from adverse local tissue reaction to wear debris. Consensus diagnostic criteria are a prerequisite for meaningful incidence estimates. Conclusion Metal hypersensitivity reactions following spinal implants appear to be an infrequently reported but clinically relevant cause of postoperative complications. This review demonstrates that presentation is variable and diagnosis remains challenging, often requiring exclusion of more common postoperative complications such as infection or mechanical failure. Although diagnostic testing lacks consistency, many—though not all—patients experienced symptom improvement following hardware removal or revision, assessed narratively rather than by validated measures. Given these findings, metal hypersensitivity should be considered in patients with persistent or unexplained symptoms after spinal surgery once other plausible diagnoses are ruled out. Further studies with standardized diagnostic criteria are required. Sources of Funding The authors received no specific funding for this work. Appendix Supporting material provided by the authors is posted with the online version of this article as a data supplement at jbjs.org (https://links.lww.com/JBJSREV/B404). This content was not copyedited or verified by JBJS.